Armata Pharmaceuticals Statistics
Total Valuation
ARMP has a market cap or net worth of $194.46 million. The enterprise value is $484.46 million.
| Market Cap | 194.46M |
| Enterprise Value | 484.46M |
Important Dates
The last earnings date was Wednesday, August 12, 2026, after market close.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ARMP has 37.18 million shares outstanding. The number of shares has increased by 0.77% in one year.
| Current Share Class | 37.18M |
| Shares Outstanding | 37.18M |
| Shares Change (YoY) | +0.77% |
| Shares Change (QoQ) | +69.84% |
| Owned by Insiders (%) | 0.55% |
| Owned by Institutions (%) | 13.43% |
| Float | 11.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 35.08 |
| Forward PS | 100.76 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 87.40 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.11
| Current Ratio | 0.11 |
| Quick Ratio | 0.11 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.65 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -25.83% |
| Return on Invested Capital (ROIC) | -28.05% |
| Return on Capital Employed (ROCE) | 22.02% |
| Weighted Average Cost of Capital (WACC) | 7.78% |
| Revenue Per Employee | $90,869 |
| Profits Per Employee | -$3.15M |
| Employee Count | 61 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +77.35% in the last 52 weeks. The beta is 1.35, so ARMP's price volatility has been higher than the market average.
| Beta (5Y) | 1.35 |
| 52-Week Price Change | +77.35% |
| 50-Day Moving Average | 4.94 |
| 200-Day Moving Average | 7.48 |
| Relative Strength Index (RSI) | 49.61 |
| Average Volume (20 Days) | 89,567 |
Short Selling Information
The latest short interest is 834,737, so 2.25% of the outstanding shares have been sold short.
| Short Interest | 834,737 |
| Short Previous Month | 704,657 |
| Short % of Shares Out | 2.25% |
| Short % of Float | 7.01% |
| Short Ratio (days to cover) | 5.48 |
Income Statement
In the last 12 months, ARMP had revenue of $5.54 million and -$192.18 million in losses. Loss per share was -$5.27.
| Revenue | 5.54M |
| Gross Profit | -12.05M |
| Operating Income | -35.28M |
| Pretax Income | -192.18M |
| Net Income | -192.18M |
| EBITDA | -33.45M |
| EBIT | -35.28M |
| Loss Per Share | -$5.27 |
Balance Sheet
The company has $23.95 million in cash and $313.95 million in debt, with a net cash position of -$290.00 million or -$7.80 per share.
| Cash & Cash Equivalents | 23.95M |
| Total Debt | 313.95M |
| Net Cash | -290.00M |
| Net Cash Per Share | -$7.80 |
| Equity (Book Value) | -231.17M |
| Book Value Per Share | -6.22 |
| Working Capital | -223.04M |
Cash Flow
In the last 12 months, operating cash flow was -$25.42 million and capital expenditures -$374,000, giving a free cash flow of -$25.79 million.
| Operating Cash Flow | -25.42M |
| Capital Expenditures | -374,000 |
| Depreciation & Amortization | 1.84M |
| Net Borrowing | 40.00M |
| Free Cash Flow | -25.79M |
| FCF Per Share | -$0.69 |
Margins
| Gross Margin | -217.36% |
| Operating Margin | -636.55% |
| Pretax Margin | -3,467.04% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ARMP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.77% |
| Shareholder Yield | -0.77% |
| Earnings Yield | -98.83% |
| FCF Yield | -13.26% |
Analyst Forecast
The average price target for ARMP is $17.50, which is 234.61% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.50 |
| Price Target Difference | 234.61% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ARMP has an Altman Z-Score of -12.22 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.22 |
| Piotroski F-Score | 2 |